Skip to main content
. 2016 Jul 4;10:59–66. doi: 10.4137/CMO.S38335

Table 2.

Dose levels, treatment duration, and outcomes.

INITIAL DOSE OF REGORAFENIB, MG/DAY n (%)
160 10 (34)
120 17 (59)
80 2 (7)
Dose modifications, n (%) 15 (51)
Dose reductions, n (%) 9 (31)
Median duration of treatment, months (range) 2.5 (0,13–11,4)
Reasons for stop, n (%)
Progression 23 (79)
Toxicity 6 (21)
Best response n* (%)
Stable disease 7 (24)
Progression disease 20 (69)

Note:

*

Missing data.